Share
2,319 Posts.
lightbulb Created with Sketch. 17
clock Created with Sketch. 04/01/17
16:02
Share
Originally posted by discursive
↑
Stumbled across this stock by accident when I miss entered the ticker of another stock I was covering. I was intrigued by this stock and looked through a few of the previous announcements and did a TA on the chart. There is a compelling case to sway this to a buy. IMO there appears to be a good support at $0.08 supported by reasonable market depth, on the flip side a run to $0.12 would be easy to achieve before first big resistance test. I'm content with the cash position, and IMO I would feel comfortable to hold this stock over the next few months whilst the clinical study is underway. The argument is strengthened considerably as its covered by various analyst reports with price targets of circa $0.330 and $0.480.
Expand
Great stock with plenty of upside IMO.
(20min delay)